Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

discoverIE, Kromek, Futura Medical, 88 Energy, Rome Resources - Small Cap Snapshot

discoverIE, Kromek, Futura Medical, 88 Energy, Rome Resources - Small Cap Snapshot

discoverIE says it's on track to meet full-year expectations after a stronger December quarter. Sales at the custom electronics group were flat, but that’s better than the 4% drop earlier in the year.

Meanwhile, Kromek Group has signed a $37.5 million deal with Siemens Healthineers, putting it on course for profitability. The agreement includes a $25 million payment this year for its radiation detection technology.

Futura Medical says sales of its erectile dysfunction gel, Eroxon, have soared to £13.7 million—up from £3.1 million last year. It’s now sold in 15 countries, with plans to hit 20 by 2025.

In resource news, 88 Energy has confirmed a major oil opportunity in Alaska, estimating up to 798 million barrels at its Canning Prospect. The low case sits at 136 million barrels, but the high case reaches 469 million.

And Rome Resources has reported strong tin grades at its Kalayi prospect in the DRC. Drilling confirms mineralisation across multiple zones, supporting its exploration model.

Follow us and subscribe on Youtube, our social channels and of course on proactiveinvestors.co.uk

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK